Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.

Ferrari, Nicola; Ward, George; Gewinner, Christina; Davis, Matthew P; Jueliger, Simone; Saini, Harpreet; Munck, Joanne; Smyth, Tomoko; Ferraldeschi, Roberta; Keer, Harold; Lyons, John; Sims, Martin J

Ferrari, Nicola; Ward, George; Gewinner, Christina; Davis, Matthew P; Jueliger, Simone; Saini, Harpreet; Munck, Joanne; Smyth, Tomoko; Ferraldeschi, Roberta; Keer, Harold; Lyons, John; Sims, Martin J.

Afiliação

Ferrari N; Astex Pharmaceuticals, Cambridge, UK; and.
Ward G; Astex Pharmaceuticals, Cambridge, UK; and.
Gewinner C; Astex Pharmaceuticals, Cambridge, UK; and.
Davis MP; Astex Pharmaceuticals, Cambridge, UK; and.
Jueliger S; Astex Pharmaceuticals, Cambridge, UK; and.
Saini H; Astex Pharmaceuticals, Cambridge, UK; and.
Munck J; Astex Pharmaceuticals, Cambridge, UK; and.
Smyth T; Astex Pharmaceuticals, Cambridge, UK; and.
Ferraldeschi R; Astex Pharmaceuticals, Cambridge, UK; and.
Keer H; Astex Pharmaceuticals, Inc., Pleasanton, CA.
Lyons J; Astex Pharmaceuticals, Cambridge, UK; and.
Sims MJ; Astex Pharmaceuticals, Cambridge, UK; and.

Blood Adv ; 5(20): 4003-4016, 2021 10 26.

Article em En | MEDLINE | ID: mdl-34474469

Assuntos

Linfoma de Células T; Neoplasias Cutâneas; Apoptose; Humanos; Imunidade; Morfolinas; Recidiva Local de Neoplasia; Piperazinas; Pirróis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Linfoma de Células T Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google